Fig. 1From: Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective studyFlow diagram exhibiting the methods applied to identify objects to evaluate survival of cisplatin-paclitaxel chemotherapy plus BEV (CPB) versus cisplatin-paclitaxel chemotherapy alone (CPA) in postmenopausal women with previously untreated advanced cervical cancer (CC)Back to article page